CDKN2A and breast cancer: We highlight studies such as Hauser et al., who reported TIMP3, APC, RAR-β2, TIG1, p16INK4a, PTGS2, p14ARF, RASSF1A and GSTP1 methylation promoters on the cell-free serum of BC patients for diagnosis [99,237].